Prednisone/Cyclophos-Phamide Treatment in Adult-Onset Autosomal Dominant Familial Focal Segmental Glomerulosclerosis (FSGS 1)

Clinical Nephrology - Germany
doi 10.5414/cnp65461
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Dustri-Verlgag Dr. Karl Feistle

Related search

First Identification of PODXL Nonsense Mutations in Autosomal Dominant Focal Segmental Glomerulosclerosis

Clinical Science
Medicine
2019English

Focal Segmental Glomerulosclerosis (FSGS) Recurrence in Kidney Allograft Recipients

2011English

MYO1EMutations and Childhood Familial Focal Segmental Glomerulosclerosis

New England Journal of Medicine
Medicine
2011English

Clinical and Genetic Heterogeneity in Familial Focal Segmental Glomerulosclerosis

Kidney International
Nephrology
1999English

Galactose Treatment in Focal and Segmental Glomerulosclerosis

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2014English

Rituximab Treatment of Adult Patients With Steroid-Resistant Focal Segmental Glomerulosclerosis

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2009English

Focal Segmental Glomerulosclerosis

American Journal of Medicine
Medicine
1974English

Response to ‘Treatment of Focal Segmental Glomerulosclerosis’

Kidney International
Nephrology
2010English

A Case Report: Familial Glucocorticoid Deficiency Associated With Familial Focal Segmental Glomerulosclerosis

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy